welcoming members from all backgrounds

Applications open for Editor-in-Chief, Fundamental and Mechanistic Neuroendocrinology strand, Journal of Neuroendocrinology

Applications open for Editor-in-Chief, Fundamental and Mechanistic Neuroendocrinology strand, Journal of Neuroendocrinology

Update: Applications now closed.


Applications are invited by the British Society for Neuroendocrinology for the position of Editor-in-Chief of the Fundamental and Mechanistic Neuroendocrinology strand of the Journal of Neuroendocrinology.

We are seeking applications for this leadership position with the prestigious Journal of Neuroendocrinology (JNE), which is owned by the British Society for Neuroendocrinology (BSN).

JNE is an international journal for the publication of original research papers and reviews across the full breadth of neuroendocrinology. It is well-established, having been in publication since 1989. The readership and importance of the journal has grown steadily, with the current impact factor standing at 3.87 and a worldwide base of subscribers, authors and readers.

The journal is published for BSN by Wiley under a contract running until 2028. Wiley provide the administrative support for peer review, using ScholarOne and a dedicated staff team, as well as carrying out all production, online publishing, and sales and marketing functions. JNE has been edited by Professor Julian Mercer (Aberdeen, UK) since 2014, and he was joined in 2020 by Professor Bob Millar (Pretoria, South Africa) when the journal was expanded to include the Translational and Clinical Neuroendocrinology (TCN) strand. Professor Mercer is Editor-in-Chief (EiC) of the Fundamental and Mechanistic (FMN) strand. The FMN EiC is in charge of the peer review function.

The growth of the journal’s remit, and moves toward Open Access (OA), make this an exciting time to become involved in the ongoing global development of a premier journal within the field of neuroendocrinology.

The successful candidate will be a recognised leader of the international neuroendocrine community and will be expected to hold an impressive track record as a published author along with senior editorial experience. Above all, the successful candidate must be passionate about JNE and demonstrate a clear vision for its future growth and development as journals move towards full OA publication.

The successful candidate will have the opportunity to be involved in the strategic development of JNE from the appointment date. The formal handover date is by agreement. Professor Millar will stand down at the end of 2024 and the new TCN Editor-in-Chief will be recruited in late 2023/early 2024.


Those interested in applying may contact Professor Mercer (j.mercer@abdn.ac.uk) and/or the BSN CEO, Sue Thorn (sue.thorn@suethorn.org), in confidence if they wish.

The BSN welcomes applicants from all backgrounds. The Editor-in-Chief can be based at any international location and would be required to join the BSN if not already a member. A financial support package will be available for the successful candidate.

Applications should include a curriculum vitae and an accompanying letter outlining the skills, experience and knowledge you would bring to this position and a summary of your vision for the FMN strand of JNE, especially how you see it flourishing as journals move from subscriptions to Open Access.

Applications will be shortlisted after the closing date, with interviews to be held on 10 and 12 May. Please send your application, in confidence, to the BSN Journal Secretary, Professor Helen Christian (helen.christian@dpag.ox.ac.uk). Applications should arrive no later than 25 April, 17.00 BST (16.00 GMT).

About JNE

Journal of Neuroendocrinology is a global, non-profit journal covering all aspects of neuroendocrine research. Providing a single home for high quality research reports and review articles from across the discipline, the Journal has two strands, Fundamental and Mechanistic Neuroendocrinology (FMN), and Translational and Clinical Neuroendocrinology (TCN). JNE is owned by the British Society for Neuroendocrinology and is also the official journal of the European Neuroendocrine Tumor Society (ENETS), the Pan American Neuroendocrinology Society (PANS), the European Neuroendocrine Association (ENEA), the International Neuroendocrine Federation (INF), Hypothalamic Neuroscience and Neuroendocrinology Australasia (HNNA), and the International Regulatory Peptide Society (IRPS).

The FMN strand of Journal of Neuroendocrinology publishes the latest ideas in classical, molecular and mechanistic neuroendocrinology and its expanding interface with the regulation of behavioural, cognitive, developmental, degenerative and metabolic processes.

The TCN strand of Journal of Neuroendocrinology publishes original translational and clinical neuroendocrinology and neuroendocrine oncology articles as well as consensus guidelines on the diagnosis and treatment of neuroendocrine disorders. It works closely with ENETS and publishes their guidance papers.

About the BSN

The BSN (www.neuroendo.org.uk) promotes research into the interactions between the endocrine and nervous systems that control so many important body processes. It supports neuroendocrinology worldwide and has members in over 30 countries. BSN’s main activities are JNE, an annual conference, support of the quadrennial International Congress of Neuroendocrinology, and a substantial grants programme.